Leerink ups 2seventy to outperform, cites attractiveness as takeover target (NASDAQ:TSVT)
monsitj Leerink has upgraded 2seventy bio (NASDAQ:TSVT) to outperform, citing the company’s attractiveness as an acquisition target. “While a commercial ...
monsitj Leerink has upgraded 2seventy bio (NASDAQ:TSVT) to outperform, citing the company’s attractiveness as an acquisition target. “While a commercial ...
Copyright © 2022 - Index Investing News.
Index Investing News is not responsible for the content of external sites.